| abstract |
The invention relates to pharmaceutical compositions comprising N- (3,5-dimethoxyphenyl) -N'- (1-methylethyl) -N- [3- (1-methyl-1H-pyrazol-4-yl) quinoxaline-6- yl] ethane-1,2-diamine, or a pharmaceutically acceptable salt thereof or a solvate thereof; to processes for the preparation of said compositions and to the use of said compositions for the manufacture of a medicament for the prophylaxis or for the treatment, in particular the treatment, of diseases, e.g. Cancer. |